Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
At steady state, plasma histamine levels exhibit circadian variations with nocturnal peaks, which is implicated in the nighttime exacerbation of allergic symptoms. However, the regulatory mechanisms are largely unexplored. This study determined how steady-state plasma histamine levels are regulated and affected by environmental factors. We found that plasma histamine levels decreased in
mast cell
-deficient mice and their circadian variations were lost in
mast cell
-deficient mice reconstituted with bone marrow-derived mast cells (BMMCs) harboring a mutation in the circadian gene Clock. Clock temporally regulates expression of
organic cation transporter 3
(
OCT3
), which is involved in histamine transport, in mast cells; OCT inhibition abolished circadian variations in plasma histamine levels. Mice housed under aberrant light/dark conditions or suffering from restraint stress exhibited de-synchronization of the
mast cell
clockwork, concomitant with the loss of circadian variations in
OCT3
expression and plasma histamine levels. The degree of compound 48/80-induced plasma extravasation in mice was correlated with plasma histamine levels. Collectively, the
mast cell
clock mediates circadian regulation of plasma histamine levels at steady state, in part by controlling
OCT3
expression, which can be modulated by stress. Additionally, we propose that plasma histamine levels potentiate
mast cell
-mediated allergic reactions.
...
PMID:Regulation of plasma histamine levels by the mast cell clock and its modulation by stress. 2807 18